Clinical Trials Logo

Clinical Trial Summary

The goal of this study was to examine the efficacy of patient-delivered partner treatment (PDPT) compared to standard partner referral (PR) and booklet enhanced partner referral (BEPR).


Clinical Trial Description

For partner treatment, index women who were diagnosed with trichomonas vaginalis and index men who were diagnosed with urethritis were randomized to one of three study arms:

Standard partner referral (PR) – index patients were instructed to tell their partners that they need to go to a clinic for STI evaluation and treatment.

Booklet-enhanced partner referral (BEPR) – index patients were given a wallet-sized booklet containing 4 tear-out cards with information for the partner and treatment guidelines for the providers that would see the partners. The partners could then present this card at a clinic to help the clinician better treat them. If index patients had more than 4 partners, they were given additional booklets.

Patient delivered partner treatment (PDPT) – index patients were given packages containing 2 gram metronidazole (for TV patients) or azithromycin 1 gram and cefixime 400 mg (for urethritis patients) for up to 4 identified sex partners. When cefixime was no longer available, ciprofloxacin 500 mg was used. These packages contained written instructions about how to take the medication, warnings about side effects and a nurse’s pager number to call if there were any questions or if the partner encountered any problems. All medications were distributed in containers with childproof caps and the partner’s initial and birthdates were written on the bottle. This was a requirement of the Louisiana State Pharmacy Board. Names were not documented on the index patient's study or medical records. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT00207467
Study type Interventional
Source Centers for Disease Control and Prevention
Contact
Status Completed
Phase Phase 2
Start date December 2001
Completion date December 2004

See also
  Status Clinical Trial Phase
Completed NCT00322465 - NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole) Phase 2
Recruiting NCT05564299 - Rapid Diagnostic Assay for Gonorrhea and Chlamydia N/A
Completed NCT00358462 - Mycoplasma Genitalium Antibiotic Susceptibility and Treatment (MEGA) Phase 3
Recruiting NCT01661985 - Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced Phase 4
Completed NCT01732172 - Chronic Inflammatory Condition of the Male Genital Tract N/A